Verve Therapeutics
VERV
#7012
Rank
NZ$0.70 B
Marketcap
$8.31
Share price
5.43%
Change (1 day)
-58.45%
Change (1 year)

Verve Therapeutics (VERV) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$0.12 Billion

According to Verve Therapeutics's latest financial reports the company's total debt is NZ$0.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Verve Therapeutics - Total debt on balance sheet (from 2020 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$0.11 B-8.2%
2022-12-31NZ$0.12 B4407.9%
2021-12-31NZ$2.86 M
2020-12-31N/A